STOCK TITAN

OmniAb Stock Price, News & Analysis

OABIW NASDAQ

Company Description

OmniAb (NASDAQ: OABIW) is a publicly traded company in the Services-commercial Physical & Biological Research sector.

OABIW stock has declined 53.1% over the past year. Shares last traded at $0.1168.

On a trailing twelve-month basis, OmniAb reported revenue of $18.7M with net income of -$64.8M and diluted earnings per share of $-0.57. The company operates at a net profit margin of -347.0%.

This page provides a comprehensive overview of OABIW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-53.09%
Performance 1 year

OmniAb (OABIW) stock last traded at $0.1168. Over the past 12 months, the stock has lost 53.1%.

OABIW Rankings

Latest News

No recent news available for OABIW.

SEC Filings

OmniAb has filed 10 recent SEC filings, including 10 Form 4. The most recent filing was submitted on June 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OABIW SEC filings →

Financial Highlights

OmniAb generated $18.7M in revenue over the trailing twelve months, operating income reached -$69.0M (-369.5% operating margin), and net income was -$64.8M, reflecting a -347.0% net profit margin. Diluted earnings per share stood at $-0.57. The company generated -$36.5M in operating cash flow. With a current ratio of 4.02, the balance sheet reflects a strong liquidity position.

$18.7M
Revenue (TTM)
-$64.8M
Net Income (TTM)
-$36.5M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in OmniAb (OABIW) currently stands at 9.6 thousand shares, down 33.6% from the previous reporting period. Over the past 12 months, short interest has decreased by 33.9%.

Days to Cover History

Last 12 Months

Days to cover for OmniAb (OABIW) currently stands at 1.1 days, down 27.2% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.1% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 319.6 days.

OABIW Company Profile & Sector Positioning

OmniAb (OABIW) operates in the Services-commercial Physical & Biological Research sector and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of OmniAb (OABIW)?

The current stock price of OmniAb (OABIW) is $0.1168 as of June 18, 2026.

What is the revenue (TTM) of OmniAb (OABIW) stock?

The trailing twelve months (TTM) revenue of OmniAb (OABIW) is $18.7M.

What is the net income of OmniAb (OABIW)?

The trailing twelve months (TTM) net income of OmniAb (OABIW) is -$64.8M.

What is the earnings per share (EPS) of OmniAb (OABIW)?

The diluted earnings per share (EPS) of OmniAb (OABIW) is $-0.57 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of OmniAb (OABIW)?

The operating cash flow of OmniAb (OABIW) is -$36.5M. Learn about cash flow.

What is the profit margin of OmniAb (OABIW)?

The net profit margin of OmniAb (OABIW) is -347.0%. Learn about profit margins.

What is the operating margin of OmniAb (OABIW)?

The operating profit margin of OmniAb (OABIW) is -369.5%. Learn about operating margins.

What is the current ratio of OmniAb (OABIW)?

The current ratio of OmniAb (OABIW) is 4.02, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of OmniAb (OABIW)?

The operating income of OmniAb (OABIW) is -$69.0M. Learn about operating income.